NCT05801068View on ClinicalTrials.gov

Perioperative Management of Factor Xa Inhibitors

NAActive, not recruitingINTERVENTIONAL
Enrollment

2,500

Participants

Timeline

Start Date

August 4, 2020

Primary Completion Date

May 15, 2024

Study Completion Date

December 31, 2025

Conditions
Atrial FibrillationAnticoagulant-induced Bleeding
Interventions
DRUG

Factor Xa Inhibitor

Hold and resume factor Xa inhibitor during perioperative/periprocedural period according to the predefined protocol.

Trial Locations (1)

03080

Seoul National university Hostpital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER